TOP 10 BIOSPECTRUM ARTICLES OF 2016
Bio Spectrum articles of 2016
In a year, Bio Spectrum covers a wide array of topics from the life sciences sector which comprises among others biotechnology and allied areas, bio-pharma and pharma, healthcare and med technology etc.
While looking back it was found out that in some of the articles, published time to time throughout the year, some basic thoughts were touched upon and a lot of new information was provided to the readers. As we enter 2017, this is an effort to fetch the readers’ attention to top 10 topics handled in depth and from varied angles by Bio Spectrum in 2016.
The Top 10 articles of 2016 deal with India’s biotech revenue target, its status in research & innovation and the possibility of its dominance in bio-similar market, besides describing the new technologies like 3-D printing, Theranostics and digital healthcare.
1. Mission $100 billion by 2025: How will Indian biotech achieve the ambition?
India has set an ambitious target of achieving $100 billion in biotech revenue by 2025. This target is one of the key points enumerated in the revised National Biotech Policy, called the National Biotechnology Development Strategy (NBDS), unveiled by the Narendra Modi government in December 2015. This target number is important. The article talks about how to achieve this figure.
2. Recreating the Silicon Valley in India
This is an article about Indian start-ups. The Silicon Valley was never planned as it is today in all its awe and grandeur. It just happened over decades! Yes, it did. Decades of hard work, persistence, high-end technology and research, and an overall conducive ecosystem laying the red carpet for all the biggies and start-ups who showed up there with their great American dreams. The article not only talks about the dreams but also shares some of the challenges. While statistics shows that 90 per cent of all start-ups fail, the more risky industries like biotechnology and pharmaceuticals are seeing innumerable start-ups in the country in an unprecedented manner. High-risk, longer gestation periods, impatient investors, and a not-so-conducive start-up environment are among a few murmurs that often slip out of entrepreneurs’ lips.
3. Emerging new wave of Theranostics
Imagine a very tiny capsule injected just below the skin of your arm. The capsule has a sensor capable of continuously measuring blood glucose levels and sending the information to your phone. Well, let’s spice it up one level above the notch. Say, when the blood glucose level crosses its threshold, visualise the tiny little capsule releasing a dose of insulin in your blood stream. What this does is offer total freedom from regular needle pricks to measure blood sugar levels, and frees patients from the anxiety of taking the right insulin doses at the right time. This is the era of Theranostics.
4. Does India need Precision Medicine Initiative?
Precision medicine in the country is considered to be at an early adoption stage. A diverse country like India, with over 4,000 population groups, and a significant percentage of consanguineous marriages presents a high-risk and prevalence of inherited genetic disorders that require attention for early diagnosis, right treatment, and management.
India has a heavy burden of inherited diseases driven by the unique genetic characteristics in the population. With 1.2 billion people, the absolute number of patients suffering from diseases in which genetics play a role is significantly large. Writer concludes saying that diseases that were previously a death sentence will be manageable, or even curable, because we will be able to individualise therapy for each patient.
5. 3D printing revolutionising healthcare
This article looks at the new innovation wave of 3D printing. Article says that today, 3D printing is an emerging technology to produce cost effective, efficient and customised body parts and medical devices such as dental implants, hearing aids, prostheses, custom made knee and hip implants, and surgical instruments.
Article also shares couple of examples on 3D priniting implementation. A 14-year-old boy from the United States has become the first person to undergo a successful nose transplant using 3D printing technology. Also recently, 3D printing has helped surgeons to successfully transplant a kidney to a toddler from Northern Ireland.
6. Can India dominate the biosimilar market?
Over the last 15 years, Indian pharmaceutical industry from having less than 5 per cent market share in the US generic market, now has more than 25 per cent. But we are yet to see the same advancements in biosimilars. Article explains how India can dominate in biosimilar market. New ‘Biosimilar Guidelines’ of India provides similarity in approach with those in the US and Europe, certainly a step in the right direction. DBT has launched plans to promote development of biosimilars. Given this scenario, India is set to make its mark in the biosimilars market, the article concludes.
7. Where India stands in research and innovation in biological sciences?
The launch of the Mangalyaan was a proud moment for Indian Science so is the contribution that the country made in the detection of gravitational waves. Atomic and space sciences are the two big areas of science where the country excels, Bio Spectrum assess research scenario in biological sciences (perhaps the most neglected) in the country.
8. Digital health: The dawn of a new era in healthcare
Technology has revolutionised almost all sectors, healthcare being no different. The convergence of technology and healthcare has opened up a whole new world of possibilities that promise to improve the quality and efficiency of various healthcare services. Bio Spectrum just did a cover story on the topic.
9. Medical devices made in India: A leap for healthcare
The global medical devices and technology market is expected to grow to $520 billion by 2020 from an estimated $3.7 billion in 2014. The Indian market is among the top twenty in the world by market size, and fourth in Asia after Japan, China and South Korea. However, the per capita spend on medical devices in India is the lowest among BRIC countries at USD 3. This article spoke about how media devices industry will improve under Make in India initiative and what would be government’s role in this.
10. Budget 2017; Will start-ups get what they want?
Start-ups are playing an important role in the Indian industry in research, innovation and new product development, particularly technology driven sectors like biotechnology. But their voice is not heard, not communicated to the policy makers. Thus, deviating from the general practice of knowing industry’s expectations from the budget, this topic tries to find out how start-ups in biotechnology sectors are looking at the Union Budget 2017 to be presented by Union Finance Minister Arun Jaitley. Experts from biotech start-ups expressed their views and the wish list.